Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.034 | 0.7 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.7 |